Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2004-09-22
2008-07-15
Navarro, Mark (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C435S174000
Reexamination Certificate
active
07399607
ABSTRACT:
The present invention provides a method of determining the presence or activity of a clostridial toxin by (a) treating with a sample, under conditions suitable for clostridial toxin protease activity, a clostridial toxin substrate which includes a fluorophore; a bulking group; and a clostridial toxin recognition sequence containing a cleavage site that intervenes between the fluorophore and the bulking group; (b) exciting the fluorophore with plane polarized light; and (c) determining fluorescence polarization of the treated substrate relative to a control substrate, where a change in fluorescence polarization of the treated substrate as compared to fluorescence polarization of the control substrate is indicative of the presence or activity of the clostridial toxin.
REFERENCES:
patent: 5693476 (1997-12-01), Scheller
patent: 5804395 (1998-09-01), Schade et al.
patent: 5804604 (1998-09-01), Frankel et al.
patent: 5962637 (1999-10-01), Shone et al.
patent: 5965699 (1999-10-01), Schmidt et al.
patent: 5981200 (1999-11-01), Tsien et al.
patent: 5989545 (1999-11-01), Foster et al.
patent: 6043042 (2000-03-01), Shone et al.
patent: 6169074 (2001-01-01), Montal et al.
patent: 6197534 (2001-03-01), Lakowicz et al.
patent: 6221355 (2001-04-01), Dowdy
patent: 6280981 (2001-08-01), Dykens et al.
patent: 6504006 (2003-01-01), Shine et al.
patent: 6511815 (2003-01-01), Burke et al.
patent: 6762280 (2004-07-01), Schmidt et al.
patent: 7183066 (2007-02-01), Fernandez-Salas et al.
patent: 7198928 (2007-04-01), Liang et al.
patent: 7208285 (2007-04-01), Steward et al.
patent: 2001/0046668 (2001-11-01), Levine et al.
patent: 2002/0127623 (2002-09-01), Minshull et al.
patent: 2003/0027752 (2003-02-01), Steward et al.
patent: 2003/0077685 (2003-04-01), Schmidt et al.
patent: 2003/0143650 (2003-07-01), Steward et al.
patent: 2003/0143651 (2003-07-01), Steward et al.
patent: 2003/0170770 (2003-09-01), Khanna et al.
patent: 2003/0219462 (2003-11-01), Steward et al.
patent: 2004/0072270 (2004-04-01), Fernandez-Salas et al.
patent: 2004/0115727 (2004-06-01), Steward et al.
patent: 2004/0146956 (2004-07-01), Khanna et al.
patent: 2004/0146963 (2004-07-01), Schmidt et al.
patent: 2004/0241782 (2004-12-01), Lopez-Calle et al.
patent: 2005/0095601 (2005-05-01), Cullum et al.
patent: 2005/0100973 (2005-05-01), Steward et al.
patent: 2005/0106655 (2005-05-01), Savage et al.
patent: 2005/0227306 (2005-10-01), Fox et al.
patent: 2005/0233429 (2005-10-01), Liang et al.
patent: 2006/0024794 (2006-02-01), Li et al.
patent: 2006/0063221 (2006-03-01), Williams et al.
patent: 2006/0063222 (2006-03-01), Williams et al.
patent: 2006/0110778 (2006-05-01), Adorante et al.
patent: 2006/0154314 (2006-07-01), Steward et al.
patent: 2007/0122858 (2007-05-01), Fernandez-Salas et al.
patent: WO 95/33850 (1995-12-01), None
patent: WO 97/34620 (1997-09-01), None
patent: WO 99/29721 (1999-06-01), None
patent: WO 99/55899 (1999-11-01), None
patent: WO 00/34308 (2000-06-01), None
patent: WO 01/18038 (2001-03-01), None
patent: WO 02/25284 (2002-03-01), None
patent: 03/020948 (2003-03-01), None
patent: WO 03/020948 (2003-03-01), None
patent: WO 2004/031355 (2004-04-01), None
patent: 2005/076785 (2005-08-01), None
Schmidt et al, J. Pro. Chem., vol. 16, No. 1, 1997.
Witcome, M et al, FEMS Immunology and Medical Microbiology, vol. 24, pp. 319-323, 1999.
Wu, Pengguang et al, Analytical Biochemistry, vol. 249, pp. 29-36, 1997, A High-Throughput STAT Binding Assay using Fluorescence polarization, especially see p. 30, col. 2, paragraph 3 “FPM2”, and entire document pp. 29-36.
Vadakkanchery V. et al, “Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: Domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage”, J. Neurochem, vol. 72, 1999, pp. 327-337.
Siegel R. et al, “Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of green fluorescent protein”, STKE, Jun. 27, 2000, pp. 1-6.
Anne et al., “High-Throughput Fluorogenic Assay for Determination of Botulinum Type B Neurotoxin Protease Activity,”Analytical Biochem.291:253-261 (2001).
Autofluorescent Proteins,AFP's Applications Manual, pp. 1-25 (Nov. 1998).
Bark, “Structure of the chicken gene for SNAP-25 reveals duplicated exon encoding distinct isoforms of the protein ,”J. Mol. Biol. 233(1):67-76 (1993).
BD Biosciences Clontech Product List, BD Living Colors™ Fluorescent Proteins, pp. 1-9 (Apr. 2004).
Burke et al., “Development and application of fluorescence polarization assays in drug discovery,”Comb Chem High Throughput Screen. 6(3):183-194 (2003).
Burnett et al., “Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity,”Biochem. Biophys. Res. Commun.. 310(1):84-93 (2003).
Calbiochem, “SNAPtide® Botulinum Toxin A Substrate, Fluorogenic,” printed on Dec. 17, 2002.
Catsicas et al., “Expression of a conserved cell-type-specific protein in nerve terminals coincides with synaptogenesis ,”Proc. Natl. Acad. Sci. U.S.A. 88(3):785-789 (1991).
Clegg, “Fluorescence Resonance Energy Transfer,”Curr. Opin. Biotechnol. 6:103-110 (1995).
Collins, “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences,”Proc. Natl. Acad. Sci. U.S.A. 99(26):16899-16903 (2002).
Cornille et al., “Solid-Phase Synthesis, Conformational Analysis and In Vitro Cleavage of Synthetic Human Synaptobrevin II 1-93 by Tetanus Toxin L Chain,”Eur. J. Biochem. 222:173-181 (1994).
Criado et al. “A single amino acid near the C terminus of the synaptosomeassociated protein of 25 kDa (SNAP-25) is essential for exocytosis in chromaffin cells,”Proc. Natl. Acad. Sci. U.S.A. 96(13):7256-7261 (1999).
Deloukas et al., “The DNA sequence and comparative analysis of human chromosome 20,”Nature414(6866):865-871 (2001).
Ekong et al., “Recombinant SNAP-25 is an Effective Substrate forClostridium botulinumType A Toxin Endopeptidase Activity in vitro,”Microbiology143:3337-3347 (1997).
Fernandes, “Technological advances in high-throughput screening,”Curr. Opin. Chem. Biol. 2(5):597-603 (1998).
Florentin et al., “A Highly Sensitive Fluorometric Assay for ‘Enkephalinase,’ a Neutral Metalloendopeptidase That Releases Tyrosine-Glycine-Glycine from Enkephalines,”Analytical Biochem. 141:62-69 (1984).
Foran et al., “Differences in the Protease Activities of Tetanus and Botulinum B Toxins Revealed by the Cleavage of Vesicle-Associated Membrane Protein and Various Sized Fragments,”Biochemistry33:15365-15374 (1994).
Geoghegan et al., “Fluorescence-based Continuous Assay for the Aspartyl Protease of Human Immunodeficiency Virus-1,”FEBS262:119-122 (1990).
Gil et al., “Modifications in the C terminus of the synaptosome-associated protein of 25 kDa (SNAP-25) and in the complementary region of a synaptobrevin affect the final steps of exocytosis,”J. Biol. Chem. 277(12):9904-9910 (2002).
Goudreau et al., “Dns-Gly-(p-NO2)Phe-βA1a, a Specific Fluorogenic Substrate for Neutral Endopeptidase 24.11,”Analytical Biochem. 219:87-95 (1994).
Graham et al., “A method to measure the interaction of Rac/Cdc42 with their binding partners using fluorescence resonance energy transfer between mutants of green fluorescent protein,”Analytical Biochem. 296:208-217 (2001).
Grys et al., “Measurement of proteases in human subgingival dental plaque by fluorescence polarization,”Arch. Oral Biol. 45(12):1101-1106 (2000).
Hallis et al., “Development of Novel Assays for Botulinum Type A and B Neurotoxins Based on Their Endopeptidase Activities,”J. Clin. Microbiol. 34:1934-1938 (1996).
Hanson and Stevens, “Cocrystal Structure of Synaptobrevin-II Bound to Botulinum Neurotoxin Type B at 2.0 Å Resolution,”Nature Structural Biology
Aoki Kei Roger
Gilmore Marcella
Steward Lance
Verhagen Marc
Williams Dudley J.
Allergan Inc.
German Joel B.
Navarro Mark
Portner Ginny
Stathakis Dean G.
LandOfFree
Fluorescence polarization assays for determining clostridial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorescence polarization assays for determining clostridial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorescence polarization assays for determining clostridial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3963759